Trial · NCT07882199

Efficacy of a Video-based, Parent-centered Home Developmental Intervention for Infants at High Risk for Developmental Delay: a Multicenter Randomized Controlled Trial

NCT07882199, Not applicable, Not yet recruiting, Seoul National University Hospital

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Efficacy of a Video-based, Parent-centered Home Developmental Intervention for Infants at High Risk for Developmental Delay: a Multicenter Randomized Controlled Trial. Trials, record NCT07882199. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882199

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Efficacy of a Video-based, Parent-centered Home Developmental Intervention for Infants at High Risk for Developmental Delay: a Multicenter Randomized Controlled Trial
NCT number: NCT07882199
Status: Not yet recruiting
Phases: Not applicable
Enrollment: 170 participants, estimated
Lead sponsor: Seoul National University Hospital
Conditions: Preterm
Interventions: Family-centered developmental training intervention
First posted: 2026-10-20
Last updated: 2026-10-20

Source ClinicalTrials.gov

Registered outcomes57

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Bayley-III Motor Composite Score	corrected age 6 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	General Movement Optimality Score-Revised	baseline	This observational assessment evaluates the quality of general movements, typically during the writhing movements period in preterm and term infants. The total score ranges from a minimum of 0 to a maximum of 38. Higher scores indicate better quality of movements, representing more optimal motor performance and a better outcome.
Secondary	General Movement Optimality Score-Revised	corrected age 6 weeks	This observational assessment evaluates the quality of general movements, typically during the writhing movements period in preterm and term infants. The total score ranges from a minimum of 0 to a maximum of 38. Higher scores indicate better quality of movements, representing more optimal motor performance and a better outcome.
Secondary	Bayley-III Cognitive Composite Score	corrected age 6 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	Bayley-III Cognitive Composite Score	corrected age 9 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	Bayley-III Cognitive Composite Score	corrected age 18 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	Bayley-III Cognitive Composite Score	corrected age 24 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	Bayley-III Cognitive Composite Score	corrected age 36 months	This measure assesses the developmental functioning of infants and toddlers. The standard composite scores for each primary domain (Cognitive, Language, and Motor) range from a minimum of 40 to a maximum of 160. Higher scores indicate better developmental performance and a better outcome.
Secondary	Motor Optimality Score-Revised	corrected age 3 months	This observational tool assesses the concurrent motor repertoire and the quality of fidgety movements in infants, typically between 3 and 5 months of post-term age. The total score ranges from a minimum of 5 to a maximum of 28. Higher scores indicate more optimal motor performance and a better outcome.
Secondary	Gross Motor Function Measure	corrected age 6 months	This observational tool evaluates changes in gross motor function. The total score is calculated as a percentage, ranging from a minimum of 0 to a maximum of 100. Higher scores indicate better gross motor function and a better outcome.

1 to 10 of 57Source ClinicalTrials.gov

See all 57 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882199

GET https://conductscience.org/api/trials/v1/NCT07882199/registered?page=2

API reference For AI assistants